SHARE: +/-: 0.10 SEK / Bid: 6.82 SEK / Ask: 6.90 SEK / Price: 6.90 SEK / High: 7.00 SEK / Low: 6.64 SEK / Quantity: 21 834 / Turnover: 147 356 SEK / 2020-07-10 15:29 (CEST)
 

Business Development

Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.

We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.

For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se